Background: Correct coding is essential for accurate reimbursement for clinical activity. Published data confirm that significant aberrations in coding occur, leading to considerable financial inaccuracies especially in interventional procedures such as endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). Previous data reported a 15% coding error for EBUS-TBNA in a UK service. Objectives: We hypothesised that greater physician involvement with coders would reduce EBUS-TBNA coding errors and financial disparity. Methods: The study was done as a prospective cohort study in the tertiary EBUS-TBNA service in Bristol. 165 consecutive patients between October 2009 and March 2012 underwent EBUS-TBNA for evaluation of unexplained mediastinal adenopathy on computed tomography. The chief coder was prospectively electronically informed of all procedures and cross-checked on a prospective database and by Trust Informatics. Cost and coding analysis was performed using the 2010-2011 tariffs. Results: All 165 procedures (100%) were coded correctly as verified by Trust Informatics. This compares favourably with the 14.4% coding inaccuracy rate for EBUS-TBNA in a previous UK prospective cohort study [odds ratio 201.1 (1.1-357.5), p = 0.006]. Projected income loss was GBP 40,000 per year in the previous study, compared to a GBP 492,195 income here with no coding-attributable loss in revenue. Conclusions: Greater physician engagement with coders prevents coding errors and financial losses which can be significant especially in interventional specialties. The intervention can be as cheap, quick and simple as a prospective email to the coding team with cross-checks by Trust Informatics and against a procedural database. We suggest that all specialties should engage more with their coders using such a simple intervention to prevent revenue losses.

Keywords:
Endobronchial ultrasound-guided transbronchial needle aspiration, Coding, Payment by results, Tariff
1.
Royal College of Physicians of London Health Informatics Unit. A Clinician's Guide to Record Standards. 2. Standards for the Structure and Content of Medical Communications when Patients Are Admitted to Hospital. London, NHS Digital and Health Information Policy Directorate, 2008. http://www.rcoa.ac.uk/docs/Clinicians-Guide-Part-2-Standards.pdf.
2.
Audit Commission. PbR Data Assurance Framework 2007/08: findings from the first year of the national clinical coding audit programme. http://www.audit-commission.gov.uk/Products/NATIONAL-REPORT/CD8608E5-A7D9-4a5a-B0F3-C161B76DE630/PbRreport.pdf. 2007/8.
3.
Audit Commission. Improving coding, costing and commissioning: annual report on the PbR data assurance programme 2010/11. http://www.audit-commission.gov.uk/health/paymentbyresults/reportsandstudies/pbr2011/Pages/pbr2011_copy.aspx.
4.
Hsia DC, Krushat WM, Fagan AB, Tebbutt JA, Kusserow RP: Accuracy of diagnostic coding for Medicare patients under the prospective-payment system. N Engl J Med 1988;318:352-355.
5.
Hsia DC: Accuracy of Medicare reimbursement for cardiac arrest. JAMA 1990;264:59-62.
6.
Muldoon JH: Structure and performance of different DRG classification systems for neonatal medicine. Pediatrics 1999;103(1 suppl E):302-318.
7.
Medford AR, Agrawal S, Free CM, Bennett JA: A performance and theoretical cost analysis of endobronchial ultrasound-guided transbronchial needle aspiration in a UK tertiary respiratory centre. QJM 2009;102:859-864.
8.
Medford AR, Agrawal S, Free CM, Bennett JA: Retrospective analysis of Healthcare Resource Group coding allocation for local anaesthetic video-assisted ‘medical' thoracoscopy in a UK tertiary respiratory centre. QJM 2009;102:329-333.
9.
Department of Health. Confirmation of payment by results (PbR) arrangements for 2011-12. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_124356. 2011.
10.
Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA: Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132(3 suppl):202S-220S.
11.
Nouraei SA, O'Hanlon S, Butler CR, Hadovsky A, Donald E, Benjamin E, et al: A multidisciplinary audit of clinical coding accuracy in otolaryngology: financial, managerial and clinical governance considerations under payment-by-results. Clin Otolaryngol 2009;34:43-51.
12.
Newbold D: Caring about the costs. Nurs Stand 2006;20:24-25.
13.
Jameson S, Reed MR: Payment by results and coding practice in the National Health Service. The importance for orthopaedic surgeons. J Bone Joint Surg Br 2007;89:1427-1430.
14.
Medford AR, Agrawal S, Free CM, Bennett JA: A prospective study of conventional transbronchial needle aspiration: performance and cost utility. Respiration 2010;79:482-489.
15.
Trisolini R, Patelli M, Gasparini S: While waiting to buy a Ferrari, do not leave your current car in the garage! Respiration 2010;79:452-453.
16.
Nallasivan S, Gillott T, Kamath S, Blow L, Goddard V: Physician involvement enhances coding accuracy to ensure national standards: an initiative to improve awareness among new junior trainees. J R Coll Physicians Edinb 2011;41:106-108.
17.
Carr ER, Pillai A: Re: A multidisciplinary audit of clinical coding accuracy in otolaryngology: financial, managerial and clinical governance considerations under payment-by-results. Clin Otolaryngol 2009;34:259-260.
18.
Medford AR: Endobronchial ultrasound-transbronchial needle aspiration and lung cancer. J R Coll Physicians Edinb 2009;39:91.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.